Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injections for pain in carpometacarpal osteoarthritis of the thumb
2024-517280-23-00Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Rhizarthrosis comparing Xeomin intra-articular injection with Placebo intra-articular injection (2 arms). Primary endpoint: Change in pain intensity on Visual Analogue Scale at 3 months. Started Oct 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on 2024-517280-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517280-23-00.